Jiangsu Recbio Technology Co., Ltd. (2179.HK)
HKD 8.0
(2.56%)
HKD 8.0
(2.56%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 22.33 Million CNY | 319.51% |
| 2022 | 5.32 Million CNY | -14.1% |
| 2021 | 6.19 Million CNY | 325.17% |
| 2020 | 1.45 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.28 Million CNY | 0.0% |
| 2024 Q1 | 4.28 Million CNY | -51.7% |
| 2023 Q4 | 8.87 Million CNY | 0.0% |
| 2023 FY | 22.33 Million CNY | 319.51% |
| 2023 Q2 | 2.29 Million CNY | 0.0% |
| 2023 Q3 | 8.87 Million CNY | 285.95% |
| 2023 Q1 | 2.29 Million CNY | 36.94% |
| 2022 Q2 | 984 Thousand CNY | 0.0% |
| 2022 Q1 | 984 Thousand CNY | -64.72% |
| 2022 FY | 5.32 Million CNY | -14.1% |
| 2022 Q4 | 1.67 Million CNY | 0.0% |
| 2022 Q3 | 1.67 Million CNY | 70.58% |
| 2021 FY | 6.19 Million CNY | 325.17% |
| 2021 Q3 | - CNY | 0.0% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q4 | 2.78 Million CNY | 0.0% |
| 2020 Q4 | 1.31 Million CNY | 0.0% |
| 2020 FY | 1.45 Million CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 392.81 Million HKD | 94.313% |
| CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 97.643% |